CS Site-Specific Factor 3

International Prognostic Index (IPI)

Notes

**Note 1**: The International Prognostic Index (IPI) has been developed for lymphomas and predicts outcome based on the following adverse factors: * Age greater than or equal to 60 years * Ann Arbor Stage III or IV * More than 1 extranodal site involved * Patient's performance status (Eastern Cooperative Oncology Group, ECOG) 2, 3, or 4 * Elevated serum lactate dehydrogenase (LDH) level **Note 2**: Record the IPI as stated in the medical record. Do not calculate points or assign risk. Only record points or risk if a physician has documented them. Use points over risk if both are available. **Note 3**: There are now three indices/scores associated with lymphoma: The International Prognostic Index (IPI, CS Site-Specific Factor 3), the Follicular Lymphoma International Prognostic Index (FLIPI, CS Site-Specific Factor 4), and the International Prognostic Score (IPS) (for Hodgkin lymphomas, CS Site-Specific Factor 5). Physicians may use these indices/scores interchangeably. For coding: * Score identified: Value in appropriate CS SSF, 999 in other two CS SSF * Score not identified, point value 5 or less: 999 in all three CS SSF * Score not identified, point value 6 or 7: Value in CS SSF 5 (IPS), 999 in other two CS SSF.

Default

988

NAACCR Item

NAACCR #2900

Metadata

CCCR_III_COLLECTED_IN_CSV1
COC_ALREADY_COLLECTED
Code Description
000 0 points
001 1 point
002 2 points
003 3 points
004 4 points
005 5 points
988 Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code 988 will result in an edit error.)
990 Stated as low risk (0-1 point)
991 Stated as low intermediate risk (2 points)
992 Stated as intermediate risk (3 points)
993 Stated as high risk (4-5 points)
999 Unknown or no information
Not documented in patient record